Cureus Study Shows AI Can Detect Alzheimer’s Early
A study published in the US-based medical journal Cureus examines how artificial intelligence is being applied to detect and predict Alzheimer’s disease at earlier stages, potentially transforming medical diagnostics, according to the journal Cureus.
The study highlights machine learning models trained on biomarker data, neuroimaging, and clinical records to identify early signs of cognitive decline years before symptoms emerge. Researchers noted AI’s potential to improve diagnostic accuracy compared to traditional methods, as reported by Cureus.
Alzheimer’s disease affects over 6 million Americans, making early intervention critical. The research suggests AI tools could enable personalized risk assessments and streamline drug development, though challenges remain in validating model reliability and addressing ethical concerns, as noted by Cureus.
The US healthcare system, facing rising costs from an aging population, may benefit from AI-driven diagnostics by reducing long-term care burdens. Cureus, a peer-reviewed journal, emphasized the need for multidisciplinary collaboration to advance AI applications in neurodegenerative disorders.
